🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and claims of rapid British shipping. Vendors market the substance there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.

Several experts said the popularity for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, risking fines, prosecution or prison.

Platform Response and Material Elimination

According to TikTok, the platform has removed problematic material and prohibited related hashtags and search suggestions. The organization stated it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Online Trading Operations

Research also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at residence.

Within minutes of joining one group, a vendor shared contact information, where most transactions take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, health issues or past usage.

Product Information and Pricing

Within these communities, messages display dark colored packages with postal service stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service said it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Although the research behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously encountered patients injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to possibly significant medical dangers”.